Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Biogen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Current portion of notes payable 0.00 3.99 4.23 4.18 4.20 0.00 0.00 0.00 0.00 0.00 5.75 5.49 5.44 0.00 0.00 0.00 0.00 0.00 0.01 0.01 2.48 2.57 2.65
Taxes payable 0.95 1.14 1.34 0.73 0.98 0.94 0.60 0.58 0.48 2.26 1.19 0.26 0.46 1.63 0.90 0.25 1.00 0.93 0.89 0.29 0.53 0.24 0.33
Accounts payable 1.54 1.73 1.69 2.47 1.80 1.53 1.80 1.85 1.60 1.50 1.49 1.95 1.39 1.43 1.43 1.47 1.34 1.23 1.33 1.67 1.29 1.52 1.49
Liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.34 0.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued expense and other 13.30 13.15 9.45 10.62 10.71 11.20 10.87 12.78 13.18 9.75 9.33 10.16 8.84 8.82 9.21 11.31 10.11 11.00 9.85 12.27 10.64 11.20 9.65
Current liabilities 15.80% 20.01% 16.71% 18.00% 17.69% 13.68% 13.27% 15.20% 15.26% 13.51% 17.76% 17.86% 16.13% 12.21% 11.91% 13.03% 12.45% 13.16% 12.08% 14.24% 14.95% 15.53% 14.12%
Notes payable, excluding current portion 25.26 25.03 26.58 26.28 26.35 29.71 30.46 30.16 29.78 29.10 17.08 16.37 16.22 22.63 22.47 23.47 23.27 24.75 22.73 25.09 25.74 27.36 28.08
Deferred tax liability 1.32 1.92 2.42 2.91 3.25 3.76 4.05 4.20 4.51 5.73 10.42 10.32 10.26 9.13 6.59 6.47 4.37 4.85 5.10 0.52 0.52 0.46 0.45
Long-term operating lease liabilities 1.43 1.09 1.32 1.38 1.46 1.49 1.59 1.63 1.64 1.63 1.55 1.52 1.49 1.61 1.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other long-term liabilities 4.82 4.66 5.45 5.53 5.54 5.54 5.92 5.40 5.73 5.78 5.20 4.95 4.99 5.16 5.12 5.49 5.93 6.09 6.29 6.89 3.11 3.45 3.25
Long-term liabilities 32.84% 32.69% 35.77% 36.10% 36.60% 40.49% 42.03% 41.39% 41.65% 42.24% 34.24% 33.16% 32.96% 38.53% 35.83% 35.44% 33.57% 35.68% 34.11% 32.50% 29.37% 31.28% 31.78%
Total liabilities 48.63% 52.70% 52.48% 54.10% 54.29% 54.17% 55.30% 56.59% 56.91% 55.75% 52.00% 51.02% 49.09% 50.74% 47.73% 48.47% 46.02% 48.84% 46.20% 46.74% 44.31% 46.81% 45.90%
Preferred stock, par value $0.001 per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, par value $0.0005 per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 0.00 0.00 0.50 0.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.00 0.00 0.41 0.26 0.09 0.00
Accumulated other comprehensive loss -0.66 -0.44 -0.49 -0.45 -0.57 -0.70 -0.73 -1.21 -0.90 -0.71 -0.57 -0.50 -0.34 -0.96 -0.83 -0.95 -0.97 -1.09 -1.16 -1.35 -1.43 -1.56 -1.53
Retained earnings 64.04 59.65 60.20 58.26 56.89 56.81 57.99 56.77 55.99 56.71 60.01 60.42 62.09 61.56 64.38 64.29 66.47 64.71 66.44 66.84 69.81 68.39 69.74
Treasury stock, at cost -11.98 -11.87 -12.61 -12.47 -12.51 -12.17 -12.48 -12.09 -11.94 -11.67 -11.40 -10.93 -10.83 -11.33 -11.26 -11.77 -11.68 -12.43 -11.41 -12.59 -12.90 -13.68 -14.05
Total Biogen Inc. shareholders’ equity 51.40% 47.34% 47.61% 45.63% 43.81% 43.94% 44.78% 43.46% 43.15% 44.33% 48.04% 48.99% 50.92% 49.27% 52.30% 51.56% 54.00% 51.19% 53.87% 53.33% 55.74% 53.24% 54.16%
Noncontrolling interests -0.04 -0.04 -0.09 0.27 1.90 1.89 -0.08 -0.06 -0.06 -0.08 -0.04 -0.02 -0.01 -0.02 -0.03 -0.03 -0.03 -0.03 -0.06 -0.06 -0.05 -0.05 -0.05
Total equity 51.37% 47.30% 47.52% 45.90% 45.71% 45.83% 44.70% 43.41% 43.09% 44.25% 48.00% 48.98% 50.91% 49.26% 52.27% 51.53% 53.98% 51.16% 53.80% 53.26% 55.69% 53.19% 54.10%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

The overall capital structure reflects a moderate fluctuation in the balance between total liabilities and total equity over the analyzed period. Total liabilities increased from approximately 45.90% in March 2017 to a peak of 56.91% in September 2020, before trending downward to 48.63% by September 2022. Conversely, total equity followed an inverse trajectory, declining from 54.10% in March 2017 to a low of 43.09% in September 2020, followed by a recovery to 51.37% by the end of the period.

Long-Term Liability Dynamics
Long-term liabilities exhibited a significant upward trend between 2017 and 2020, rising from 31.78% to a peak of 42.24% in June 2020. This growth was primarily driven by non-current notes payable, which reached a high of 30.46% in March 2021. However, a subsequent reduction is observed, with long-term liabilities receding to 32.84% by September 2022, suggesting a period of debt repayment or a shift in financing strategy.
Current Liability Trends
Current liabilities remained relatively stable, generally oscillating between 12% and 18% of total liabilities and equity. A notable peak occurred in June 2022, where current liabilities reached 20.01%. Accrued expenses and other current liabilities remained the most significant component of this category, consistently representing between 8.8% and 13.3% of the total balance sheet.
Deferred Tax Liability Volatility
A distinct pattern is observed in deferred tax liabilities, which rose sharply from below 1% in 2017 to a peak of 10.42% in March 2020. Following this peak, there was a steady and consistent decline, ending at 1.32% in September 2022. This suggests a significant reversal of temporary differences or changes in tax positioning over the five-year span.
Equity Composition and Retained Earnings
Retained earnings serve as the primary driver of total equity. These earnings decreased from 69.74% in March 2017 to 55.99% in September 2020, aligning with the overall dip in equity. A recovery followed, with retained earnings climbing back to 64.04% by September 2022. This indicates a strong capacity for internal capital generation in the latter half of the period.
Treasury Stock and Capital Returns
Treasury stock maintained a consistent negative impact on total equity, typically ranging between -10.8% and -14.1%. This persistent negative value indicates an ongoing corporate strategy of share repurchases, which effectively reduces the total equity percentage relative to total liabilities.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?